Our facilities have been successfully inspected by the U.S. Food & Drug Administration (USFDA) and classified as Voluntary Action Indicated (VAI). This rating reflects our adherence to stringent cGMP (current Good Manufacturing Practice) norms with only minor observations, enabling us to export to the regulated U.S. market.

We are certified by the EDQM, allowing us to supply high-quality APIs to the European Union. This approval confirms our compliance with EU GMP standards and quality assurance systems.

Emnar Pharma holds KFDA approval, permitting exports to South Korea. Our facilities meet all regulatory and GMP requirements established by the Korean authorities.

All our units follow WHO-GMP guidelines for pharmaceutical production. We implement robust quality systems and SOPs at every step, from raw material procurement to finished goods dispatch.